Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 08/04/26
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and WebcastBusiness Wire • 07/24/26
Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in BloodBusiness Wire • 07/15/26
Bruker Corporation (BRKR) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/08/26
Bruker (BRKR) Up 37.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/05/26
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026Business Wire • 06/04/26
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy IndustryBusiness Wire • 06/02/26
Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease BiologyBusiness Wire • 06/01/26
Champalimaud Foundation's Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRIBusiness Wire • 05/26/26
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/29/26
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and WebcastBusiness Wire • 04/24/26
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026Business Wire • 04/17/26
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026Business Wire • 04/17/26
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak ManagementBusiness Wire • 04/17/26